| 4Q26 |
$3,646.455 |
−$28.223 |
up to 40 Units |
Inj. (ani), up to 40 units |
v1, posted September 17, 2026 |
| 3Q26 |
$3,674.678 |
+$103.327 |
up to 40 Units |
Inj. (ani), up to 40 units |
v1, posted September 15, 2026 |
| 2Q26 |
$3,571.351 |
+$19.612 |
up to 40 Units |
Inj. (ani), up to 40 units |
v1, posted September 15, 2026 |
| 1Q26 |
$3,551.739 |
+$17.138 |
up to 40 Units |
Inj. (ani), up to 40 units |
v1, posted September 15, 2026 |
| 4Q25 |
$3,534.601 |
−$12.718 |
up to 40 Units |
Inj. (ani), up to 40 units |
v1, posted September 8, 2026 |
| 3Q25 |
$3,547.319 |
+$101.735 |
up to 40 Units |
Inj. (ani), up to 40 units |
v1, posted March 10, 2026 |
| 2Q25 |
$3,445.584 |
−$23.264 |
up to 40 Units |
Inj. (ani), up to 40 units |
v1, posted March 10, 2026 |
| 1Q25 |
$3,468.848 |
+$51.877 |
up to 40 Units |
Inj. (ani), up to 40 units |
v1, posted December 19, 2025 |
| 4Q24 |
$3,416.971 |
−$64.015 |
up to 40 Units |
Inj. (ani), up to 40 units |
v1, posted June 11, 2025 |
| 3Q24 |
$3,480.986 |
+$115.683 |
up to 40 Units |
Inj. (ani), up to 40 units |
v1, posted June 11, 2025 |
| 2Q24 |
$3,365.303 |
+$16.312 |
up to 40 Units |
Inj. (ani), up to 40 units |
v1, posted March 11, 2025 |
| 1Q24 |
$3,348.991 |
– |
up to 40 Units |
Inj. (ani), up to 40 units |
v1, posted December 19, 2024 |